AQL™ Technology Advantage

The AQL™ drug delivery technology combines a novel liposome formation method that is used to encapsulate a compound that then is used to drive the drug into the liposome in the second step. The resulting liposome formulation has a high concentration of drug within the particle, and then releases the drug very slowly after subcutaneous injection in animals.